A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer

Published:2022-02 Issue: Volume:119 Page:105505
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Lier Svenja,Sellmer Andreas,Orben Felix,Heinzlmeir Stephanie,Krauß Lukas,Schneeweis Christian,Hassan Zonera,Schneider Carolin,Patricia Gloria Schäfer Arlett,Pongratz Herwig,Engleitner Thomas,Öllinger Rupert,Kuisl Anna,Bassermann Florian,Schlag Christoph,Kong Bo,Dove Stefan,Kuster Bernhard,Rad Roland,Reichert Maximilian,Wirth Matthias,Saur Dieter,Mahboobi Siavosh,Schneider Günter

Funder

Deutsche Krebshilfe

Wilhelm Sander-Stiftung

Deutsche Forschungsgemeinschaft

TU Munich

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference41 articles.

1. Targeted protein degradation: expanding the toolbox;Schapira;Nat. Rev. Drug Discov.,2019

2. Development of targeted protein degradation therapeutics;Chamberlain;Nat. Chem. Biol.,2019

3. Harnessing the Power of Proteolysis for Targeted Protein Inactivation;Verma;Mol. Cell,2020

4. Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery;Burslem;Cell,2020

5. Phthalimide conjugation as a strategy for in vivo target protein degradation;Winter;Science,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Potential of GSPT1 as a novel target for glioblastoma therapy;Cell Death & Disease;2024-08-08

3. Small-Molecule Approaches to Target Transcription Factors;Annual Review of Cancer Biology;2024-06-12

4. Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505];Bioorganic Chemistry;2024-05

5. Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma;Cancer and Metastasis Reviews;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3